Navigant Consulting (NYSE:NCI) Downgraded to Market Perform at Barrington Research

Share on StockTwits

Navigant Consulting (NYSE:NCI) was downgraded by equities research analysts at Barrington Research from an “outperform” rating to a “market perform” rating in a report issued on Tuesday, The Fly reports.

A number of other research firms also recently weighed in on NCI. Sidoti downgraded Navigant Consulting from a “buy” rating to a “neutral” rating in a report on Friday, August 2nd. TheStreet upgraded Navigant Consulting from a “c+” rating to a “b-” rating in a report on Tuesday, June 18th.

NYSE NCI traded down $0.02 on Tuesday, reaching $27.82. The company had a trading volume of 46,660 shares, compared to its average volume of 736,466. The firm has a market cap of $1.07 billion, a price-to-earnings ratio of 59.19, a P/E/G ratio of 2.25 and a beta of 0.72. Navigant Consulting has a fifty-two week low of $18.85 and a fifty-two week high of $28.21. The business has a 50 day moving average of $25.28 and a two-hundred day moving average of $23.09. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.45 and a quick ratio of 2.45.

Navigant Consulting (NYSE:NCI) last posted its quarterly earnings data on Friday, August 2nd. The business services provider reported $0.29 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.07. The business had revenue of $196.57 million during the quarter, compared to the consensus estimate of $186.77 million. Navigant Consulting had a return on equity of 4.21% and a net margin of 11.57%. As a group, research analysts predict that Navigant Consulting will post 0.92 earnings per share for the current fiscal year.

Institutional investors have recently modified their holdings of the business. UBS Group AG increased its stake in Navigant Consulting by 11.4% in the 2nd quarter. UBS Group AG now owns 430,590 shares of the business services provider’s stock valued at $9,985,000 after buying an additional 43,941 shares during the last quarter. United Services Automobile Association increased its stake in Navigant Consulting by 4.1% in the 2nd quarter. United Services Automobile Association now owns 372,889 shares of the business services provider’s stock valued at $8,647,000 after buying an additional 14,530 shares during the last quarter. Nuveen Asset Management LLC purchased a new stake in Navigant Consulting in the 2nd quarter valued at about $5,324,000. UBS Asset Management Americas Inc. increased its stake in Navigant Consulting by 95.7% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 37,318 shares of the business services provider’s stock valued at $865,000 after buying an additional 18,252 shares during the last quarter. Finally, Jane Street Group LLC purchased a new stake in Navigant Consulting in the 2nd quarter valued at about $223,000. Hedge funds and other institutional investors own 94.93% of the company’s stock.

About Navigant Consulting

Navigant Consulting, Inc provides professional services worldwide. It operates through three segments: Healthcare, Energy, and Financial Services Advisory and Compliance. The Healthcare segment offers consulting and business process management services to healthcare providers, payers, and life sciences companies.

See Also: What are catch-up contributions?

The Fly

Receive News & Ratings for Navigant Consulting Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navigant Consulting and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies
LegacyTexas Financial Group  Raised to Buy at BidaskClub
LegacyTexas Financial Group Raised to Buy at BidaskClub
Adverum Biotechnologies  PT Lowered to $8.00 at SunTrust Banks
Adverum Biotechnologies PT Lowered to $8.00 at SunTrust Banks


 
© 2006-2019 Zolmax.